Bankwell Financial Group Inc Q2 2026 Earnings Call
Key Takeaways
- Bankwell Financial Group reported GAAP net income of $12.4 million, or $1.52 per share, in Q2 2026, up from $11.3 million, or $1.41 per share, in Q1 2026.
- Loan balances grew by $93 million, or 3.2% sequentially, reaching $3 billion at quarter end, with new originations outpacing portfolio runoff.
- Core deposits increased by $128 million during the quarter, including $72 million growth in non-interest bearing accounts and $44 million in analyzed checking balances.
- Wholesale funding was reduced by $44 million this quarter, with brokered deposits down $520 million or 51% since end of 2022.
- Core deposits grew 19% year over year, totaling $356 million increase.
- Net interest margin expanded 30 basis points quarter over quarter to 3.50%, driven by favorable repricing on both sides of the balance sheet.
- Non-interest income was $3.3 million, led by $2.4 million gain on sale income from the SBA division.
- SBA loan sale gains for the first half of 2026 were $4.8 million, compared to $1.5 million in the first half of 2025.
- Total nonperforming loans decreased by $3.2 million to $15.9 million, with nonperforming assets at 46 basis points of total assets.
- Reserve coverage on nonperforming loans strengthened to approximately 193%.
- Tangible book value per share increased by $2.41 in the first half of 2026 to $40.25.
- Return on average assets was 1.46% and return on average tangible common equity was 15.61% for the quarter.
- Pre-provision net revenue rose 31.4% to $17.5 million, or 2.07% of average assets, driven by higher net interest income and improved efficiency.
- Net interest income totaled $29.5 million, up from $26.9 million in the prior quarter.
- Net interest margin expanded to 3.58%, with deposit costs improving 16 basis points to 2.94% and earning asset yields rising 11 basis points to 6.26%.
- Non-interest expense fell to $15.3 million from $16.9 million, primarily due to lower salaries and benefits.
- Provision for loan losses was $1.2 million, with the allowance at 1.03% of total loans.
- Total assets ended the quarter at $3.5 billion and deposits at $3 billion.
- Shareholders equity grew to $323.5 million, with the bank well capitalized including a total capital ratio of 12.7% and CET1 ratio of 11.66%.
- $0.6 billion of time deposits were repriced in the first half of 2026, generating an annualized benefit of $2.3 million, though this benefit will diminish in future quarters.
- Approximately 43% of loans are now floating rate, nearly double the 23% at the end of 2024, positioning the balance sheet towards rate neutrality.
Outlook
- The healthcare lending business is experiencing strength in cash flows and revenue growth, with expense control improving due to sufficient labor availability.
- The senior housing sector headwinds appear largely behind in the states where Bankwell originates, though competition in lending has increased as other banks and non-bank lenders have returned to the market.
- Bankwell maintains strong execution and does not typically compete on price in healthcare lending, preserving spreads.
Guidance
- Bankwell raised its full year 2026 loan growth guidance to 5% to 7%.
- Full year net interest income outlook was increased to a range of $115 million to $117 million.
- The previous full year guidance for non-interest income of $12 million to $13 million was affirmed.
- Full year non-interest expense guidance was raised to $65 million to $67 million to support targeted investments in talent and infrastructure and to appropriately compensate teams.
- Despite higher expense guidance, management expects no negative impact on the efficiency ratio due to increased revenue.
- Management expects net interest margin to expand modestly into Q3 2026, with margin benefits from time deposit repricing diminishing in Q4 and beyond as maturities reprice closer to current market levels.
Executive Comments
- CEO Chris Gruseke highlighted strong execution, margin expansion, robust deposit and loan growth, and progress on strategic priorities including SBA division success.
- CFO Courtney Sacchetti emphasized outstanding profitability metrics, improved efficiency, and a strong balance sheet with well-capitalized ratios.
- Management noted the importance of investing in people and technology to sustain growth and operating leverage.
- Management described the SBA division as a controlled and risk-managed growth area, with production intentionally kept steady.
- Loan growth is driven primarily by deepening relationships with existing customers rather than acquiring new ones, across asset classes including healthcare, investor CRE, and CNI.
- Expense increases reflect meritocratic incentive compensation tied to strong performance and investments in technology and personnel, supporting scale and growth.
- Management expects expense run rate to increase with continued production growth but remain aligned with efficiency improvements.
- The company is focused on maximizing tangible book value per share while balancing risk.
Q&A
- Loan growth acceleration is due to revised assumptions on runoff and increased loan originations to fill expected runoff, driven by deepening existing customer relationships rather than new customer acquisition.
- Brokered deposit reductions are expected to continue drifting down organically over time but management does not have a specific target to reach below 10% within 12 months.
- Net interest margin is expected to expand modestly into Q3 2026 due to remaining time deposit repricing, with margin benefits diminishing in Q4 and beyond.
- The expense guidance increase is primarily due to higher compensation reflecting strong performance, along with investments in technology and personnel; efficiency ratio is expected to improve or remain stable despite higher expenses.
- Nonperforming loans outlook is positive with paths to further reductions; reserves are considered appropriate with no significant specific reserves on real estate portfolio.
- SBA business production is controlled for risk management, with no plans to increase origination targets despite strong gains on sale.
- Healthcare lending sees improving fundamentals with controlled expenses and strong execution, though competition has increased as other lenders return to the market; pricing remains stable as Bankwell competes on execution rather than price.
- Expense increases tied to incentive compensation are expected to correlate with revenue growth and profitability, and may persist as long as performance continues.
- Profitability metrics such as ROA around 1.40% to 1.46% are consistent with current guidance and expected to continue barring changes in the environment.
I'll now hand the conference over to Courtney Sacchetti, Executive Vice President and Chief Financial Officer. Courtney, please go ahead. Thank you.
Good morning, everyone. Welcome to Bankwell's second quarter 2026 earnings conference call. To access the call over the internet and review the presentation materials that we will reference on the call, please visit our website at investor.mybankwell.com and go to the Events and Presentations tab for supporting materials. Our second quarter earnings release is also available on our website. Our remarks today may contain forward-looking statements and may refer to non-GAAP financial measures. All participants should refer to our SEC filings, including those found on Forms 8-K, 10-Q, and 10-K, for a complete discussion of forward-looking statements and any factors that could cause actual results to differ from those statements. Now I will turn the call over to Chris Gruseke, Bankwell's Chief Executive Officer.
Thanks, Courtney. Welcome, and thank you to everyone for joining Bankwell's quarterly earnings call. This morning, I'm joined by Courtney Sacchetti, our CFO, and Matt McNeill, our President and Chief Banking Officer. Thank you for your continued interest in Bankwell and for the chance to share our second quarter results with you. Second quarter marked another period of strong execution with meaningful margin expansion, robust core deposit and loan growth, and continued progress on our strategic priorities, including the continued success of our SBA division. For the second quarter, we reported GAAP net income of $12.4 million, or $1.52 per share, compared to $11.3 million, or $1.41 per share for Q1. Loan growth accelerated this quarter with balances growing by $93 million or by 3.2% sequentially. Gross loans stood at $3 billion at quarter end as new originations continue to outpace portfolio runoff.
Core deposits increased by $128 million during the quarter. Importantly, this includes $72 million of growth in non-interest bearing and NOW accounts. Growth in non-interest-bearing deposits included approximately $44 million in increased analyzed checking balances. On a year-to-date basis, analyzed checking has grown by approximately $68 million or roughly 17%. In addition to funding loan growth, our strong performance in growing core deposits has enabled us to reduce wholesale funding by $44 million this quarter. Since its peak at the end of 2022, we've now reduced brokered balances by $520 million or by roughly 51%. This continued progress is a result of strong execution across the entire franchise as we continue to strengthen our funding base and deepen client relationships. Compared to the same quarter in the prior year, core deposits have grown by $356 million or by 19%.
The net interest margin was 358 basis points, an expansion of 30 basis points from the prior quarter, driven by favorable repricing dynamics on both sides of the balance sheet. Courtney will walk through those details in a couple of minutes. Non-interest income remained a meaningful contributor to our results, totaling $3.3 million for the quarter. This was led by our SBA division, which contributed $2.4 million of gain on sale income. For the first half of this year, SBA loan sale gains were $4.8 million compared to $1.5 million in the first half of 2025. This business remains an important and growing part of diversifying our revenue stream. Credit quality continues to improve. Total non-performing loans decreased by $3.2 million to $15.9 million, and non-performing assets as a percentage of total assets declined by 10 basis points to 46 basis points.
Reserve coverage of non-performing loans strengthened to approximately 193%. As stewards of our shareholders' capital, our primary focus has always been to maximize tangible book value per share while balancing the risks of running our business. We've added $2.41 to tangible book value per share in the first half of 2026 to reach $40.25 per share. I'll now turn the call back to Courtney to walk through the financial results in more detail.
Thanks, Chris. Profitability for the quarter was outstanding. Return on average assets was 1.46%, and return on average tangible common equity was 15.61%. Pre-provision net revenue rose 31.4% to $17.5 million or 2.07% of average assets, up from $13.3 million last quarter, driven by higher net interest income and improved efficiency. Net interest income totaled $29.5 million, up from $26.9 million in the prior quarter. Net interest margin expanded 30 basis points to 3.58%, driven by favorable repricing. Deposit cost improved 16 basis points to 2.94%, while our earning asset yields rose 11 basis points to 6.26% as new loan production at an average rate of 7.16% continued to outpace runoff. Non-interest income totaled $3.3 million for the quarter, including $2.4 million of gains on SBA loan sales.
Non-interest expense fell to $15.3 million from $16.9 million, primarily on lower salaries and benefits as the first quarter carried seasonal compensation costs. Operating leverage continued to build as evidenced by this quarter's 47.5% efficiency ratio, bringing the year-to-date ratio to 51.4%. Provision for credit losses was $1.2 million, driven by loan growth. The allowance ended the quarter at 1.03% of total loans, with non-performing loan coverage of approximately 193%. The balance sheet remains strong. Total assets ended the quarter at $3.5 billion, and deposits at $3 billion. Shareholders' equity grew to $323.5 million. As Chris commented, our fully diluted tangible book value per share rose to $40.25. Both the bank and the holding company remain well capitalized, with the bank's total capital ratio of 12.7%, common equity Tier 1 ratio of 11.66%, and a leverage ratio of 10.36%.
Finally, we repriced $0.6 billion of time deposits in the first half of the year at a 36 basis point improvement, representing an annualized benefit of $2.3 million. Looking ahead, that benefit will diminish, as much of our higher-cost time deposits have already been repriced, and the remaining maturities carry rates closer to current market levels. As that benefit moderates, we are increasingly positioned towards a more rate-neutral balance sheet. Approximately 43%, or $1.3 billion of our loans are now floating rate, nearly double the 23% we carried at the end of 2024. This increase in floating rate assets provides a more balanced sensitivity across a range of rate scenarios. In the immediate term, we're modestly asset sensitive. Roughly $1.6 billion of loans and cash reprice right away, while $250 million of Fed funds index deposits move with them.
Over the following 12 months, that gap narrows towards neutral as $1.1 billion of time deposits mature and reprice, and our core non-maturity deposits gradually adjust. That's the financial picture for the quarter. I'll turn it back to Chris for closing remarks.
Thanks, Courtney. Our second quarter results demonstrate the earnings power of the franchise we've been building deliberately over time. In our investor presentation for Q3 of 2024, we laid out plans to invest in our deposit franchise, pay down wholesale funding, increase non-interest income, and grow our consolidated Tier 1 capital ratio. We committed to invest in the people and technologies necessary for the company's ongoing success, and to do so in a manner which would increase our operating leverage. Halfway through 2026, we're excited to have seen so many of our aspirations realized. Given our first half performance and the momentum we're carrying into the second half of the year, we're pleased to increase our full year guidance across several measures. We now expect loan growth of 5%-7%, and we are raising our full year net interest income outlook to a range of $115 million-$117 million.
We affirm our previous full year guidance of $12 million-$13 million for non-interest income. Given our momentum this year, we are making targeted investments in talent and infrastructure to support continued growth and to compensate appropriately our teams for the strong performance they've delivered. Accordingly, we're raising our full year non-interest expense guide to $65 million-$67 million. With our updated revenue guidance, we expect no negative impact to our efficiency ratio from our increased expense guide. None of the progress we've achieved can happen without the people behind it. I especially want to recognize our team, whose dedication and efforts are what turn our strategy into results, our customers who place their trust in us, and the shareholders who share our long-term vision. We're grateful to all of you and remain focused on delivering pure leading results in the quarters to come.
Now, operator, we are ready to open the line for questions.
We will now begin the question and answer session. If you would like to ask a question, please press *1 to raise your hand. To withdraw your question, press *1 again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Feddie Strickland with Hovde Group. Feddie, your line is open. Please go ahead. Hey. Good morning, everybody.
Just wanted to start off really on the loan growth here. I was just wondering if you could talk a little bit about what's changed to drive the higher loan growth. Is that future growth still predominantly C&I driven like this quarter?
Yeah. Good morning, Feddie. Hi. Going to hand that to Matt.
Really, the loan growth is a function of us raising our projections on assumptions on runoff. We had a lot of loans refinance away from us or leave the bank last year. It impacted our ability to grow the loan book early in the year. We looked at those assumptions and raised them. We've kept them raised through the first half of this year, and that's really been the change. Just originating more loans to fill the expected runoff.
Is that driven by increased activity from existing customers or reaching out to new customers? I guess I'm just trying to get a sense for Maybe whether sentiment improved or anything else just as the originations increase?
We're very relationship-driven. We don't bring on large quantities of new customers. We're really focused on deepening relationships with existing customers and rinse and repeat asset classes. It's really driven by deepening relationships with our existing customers. That's across all the healthcare, goes into investor CRE, C&I, all the places we originate.
Feddie, it's more art than science. It's managing the flows. When you have a feel for what the prepayment should be, then we look forward the next quarter, we can prime the pump and price and speak accordingly to manage the flows.
All right, great. That's super helpful. Thank you. In switching to the other side of the balance sheet, you've made really good progress in reducing the brokered funding over the past couple quarters. I think we're down to about 17% or so of deposits. How should we think about that brokered number over time over the next year or so? Do you think you could get that sub 10 in the next 12 months? Is it just kind of too hard to tell at this point?
It's not too hard to tell. I think sub 10 would sound aggressive. I think it'll come down naturally over time because we are still trying to build consolidated capital at the hold co. While we're on this kind of trajectory and the way it's gone these last several quarters, it feels just like organically we're generating more deposits than the amount of loans that we would want to book while still growing capital. I'd expect to see it kind of drift down over time as that plays out. We don't have a target in mind.
Understood. Last quick question from me, just should we expect a slight grind higher in the margin if the yield curve stays where it is, just given you've still got above portfolio yields and new production and maybe it sounds like flattish deposit costs with some of the time deposits tailwind going away?
Hey, Feddie, it's Courtney. Yes, I would expect our margin to expand a little bit more into the third quarter. We still have some room left in our time deposits in the third quarter. It's really fourth quarter and beyond where we start to see the runoff kind of matching current market rates. We do expect a margin expansion given no other changes.
Understood. I appreciate it, Chris Gruseke, Courtney Sacchetti, and Matt McNeill. Impressive quarter. I'll step back.
Thanks, Feddie. Thanks, Feddie. Your next question comes from the line of Mark Shutley with KBW.
Mark, your line is open.
Hey, thanks. Good morning. Good morning, Mark.
Hey. I was surprised to see the expense guide move up after expense control was really strong in the quarter. I know you talked about compensation drifting higher. I just was wondering if you could talk through any other puts and takes there. Thanks. Yeah. Without specifics of what comprises it, in the earnings release we offer, I think as well just now, we said that despite increasing the guide, if you have numbers worked up based on our revenue guidance prior and now current, that we would not expect that to impact the efficiency ratio in a negative manner.
We're really talking about scale. As you have a year that's going well and doing better, we run a meritocratic incentive plan. If people do better, we want them to get paid. That's a good part of the increase as well. We have been investing in technology and processes and bringing on additional people, but the scale's working for us. I think early in the year, we talked about expenses and said if we're adding expenses, it's because we're making more money and we're going to return the expense.
Chris Gruseke, I will just add to that is that our guidance from the last time we gave guidance, if you did a rough calculation of what that efficiency ratio would be, it was a range of 52.8% to 51.2%. This new guidance keeps that high end. It's exactly 52.8 and lowers the best case scenario to 50%. It is in line with, from an efficiency ratio perspective, it actually is improved.
Okay, great. That's helpful. Then maybe shifting over to credit. NPA has improved again. I was wondering if you could update us on sort of that remaining non-performer bucket then should we expect reserves to be relatively stable from here through the year? Thank you. Our outlook on the remaining non-performing loans is good.
We see some paths to reducing that number even further in the coming quarters. I'll let Courtney Sacchetti comment on the reserve.
We've taken the write-downs as appropriate. We don't really carry a lot of specific reserves specifically on our real estate portfolio. We feel it's marked appropriately based on the information we have.
Okay, great. That's it from me. Thanks for taking my questions.
Your next question comes from the line of Steve Moss with Raymond James. Steve, please go ahead. Good morning.
Maybe just starting with just the SBA business here. You guys didn't change your guide on non-interest income, but it's definitely trending strong, and I realize it's probably nitpicking a little bit, but just kind of curious on any updated thoughts you have there.
I'm sorry, Steve, you broke up a little bit. Could you repeat that question?
No, I'm good. Sorry. Sorry about that.
No worries. It seems to be my phone today for some reason. On the SBA business here, gains have been trending fairly strong. I realize you guys didn't change the non-interest income guide. I'm just kind of curious here in terms of the business activity there and maybe if there's just some upside you want to see another quarter of trends before taking things up there.
We intentionally are keeping our SBA production controlled. We're still retaining a portion of non-SBA-guaranteed portions of those loans. For risk management purposes, we're going slow and steady. We don't anticipate raising our origination targets there to try to keep up with the other side of the business. It's really risk management, a new division.
Okay been after it for about two and a half years, although we've been originating SBA for more than 10.
This new division is just two and a half years old.
Okay. Appreciate that color there. The other thing here, just in terms of the healthcare business, just kind of curious, can you just talk about the trends you're seeing? How are businesses faring? I know there were some challenges called six to 12 months ago in terms of the ability to refinance the permanent market and get revenues to where they wanted to be. Just curious on that aspect of things and also the competitive landscape for lending into that market.
We're very particular about the states where we originate for senior housing particularly, which is where Those headwinds are largely behind the industry. The places where we originate, we're seeing a lot of strength in cash flows. We're seeing growth in revenue, expenses being controlled. The expense control is largely due to having enough labor to operate the facilities and not having to go to agency. All of those headwinds seem to be behind the operators for now in the states where we're originating our business. We think this is a very good time to be in the business. Other banks have now come to that conclusion as well, the lending activity amongst other banks and non-bank lenders is up. Many people have come back to the market. It is more competitive. We are fortunate in the fact that our customers come to us for our strong execution.
That hasn't changed, we still have as much access as we want to the market.
Okay. Just in terms of pricing, is it incrementally more competitive or spread tightening materially? Just kind of curious there.
We don't often compete on price. Like I said, execution is the strong driver of our value creation for our clients. We keep our spread where they are, and that hasn't been a problem for us.
Okay. Great. I appreciate that. The rest of my questions have been asked and answered here. Thanks very much. Nice quarter here.
Thank you. Thanks, Steve. We also have a follow-up from Feddie Strickland of Hovde Group.
Freddie, your line is open. Please go ahead. Hey, just two quick follow-ups.
One on expenses. Totally understand compensating folks for good production. As I think through the back half of 2026, I know you haven't given 2027 guidance, but if we see the expenses step up in the back half on maybe some incentive comp, should I expect that to carry through into 2027, or is that kind of a one-time thing until we get through 2027? A long-winded way of asking could we maybe see expenses step down a little bit in the first quarter of 2027 after maybe a little bit higher expenses in the back half of the year? Is this more salary related?
I would think it's more salary related. I would think that our run rate will tick up as long as our production continues on the path that it's on. Right? Again, as we perform well, the company will compensate accordingly. The expectation would be the run rate would start to tick up.
That would be correlated with performance.
Yeah. We'll come back to that number will grow to reflect comp incentive performance.
The only way that's going to happen is if the top line is growing and profitability metrics continue to increase. We don't want to be in the business, and won't be in the business of increasing expenses and decreasing our efficiency ratio. Just want to be clear, this is about scale.
Understood. At the end of the day, it just sounds like I should really pay attention to efficiency really more than anything. Because if you've got increased revenue, you may have some increased expenses just to make sure you're compensating folks.
Yes. Right now, we agree with that.
Yes. Okay. One more from me.
Just in terms of overall profitability, 15% ROATCE, 146 ROA, really strong. Is a 140-ish, 135, 140-ish ROA a good go-forward number for you guys? I know you haven't given formal guidance on those profitability metrics, but I'm just trying to think through whether this quarter's profitability carries forward or kind of what you expect in terms of those metrics.
Well, I think with a little bit of math, and I'm not trying to be cute, Freddie. I think if we lay out the expenses and non-interest income and the revenue guidance that we've given, you can kind of get to the numbers pretty close. Yeah, we're not surprised that they increased this quarter, and we see no reason for them to decrease, unless the world changes.
Fair enough. Thanks for taking my follow-ups. I appreciate it. Thank you very much.
There are no further questions at this time. This concludes today's call. Thank you for attending.
